Abbott Laboratories (ABT) Other Non Operating Income (2009 - 2026)

Abbott Laboratories' Other Non Operating Income history runs 18 years deep, the most recent figure standing at $13.0 million for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 89.76% year-over-year to $13.0 million; the TTM figure through Mar 2026 stood at $434.0 million (down 27.3% YoY), while the FY2025 annual figure was $548.0 million, up 45.74% from the prior year.
• Other Non Operating Income came in at $13.0 million for Q1 2026 at Abbott Laboratories, down from $134.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $496.0 million in Q4 2023 to a low of -$19.0 million in Q3 2022.
• A 5-year average of $131.9 million and a median of $124.0 million in 2024 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income tumbled 300.0% in 2023 and surged 1470.0% in 2025, its largest moves.
• Abbott Laboratories' Other Non Operating Income stood at $337.0 million in 2022, then jumped by 47.18% to $496.0 million in 2023, then fell by 27.62% to $359.0 million in 2024, then plunged by 62.67% to $134.0 million in 2025, then plunged by 90.3% to $13.0 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $13.0 million, $134.0 million, and $150.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison